Your browser doesn't support javascript.
loading
COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout.
Barry, Mazin; Temsah, Mohamad-Hani; Aljamaan, Fadi; Saddik, Basema; Al-Eyadhy, Ayman; Alenezi, Shuliweeh; Alamro, Nurah; Alhuzaimi, Abdullah N; Alhaboob, Ali; Alhasan, Khalid; Alsohime, Fahad; Alaraj, Ali; Halwani, Rabih; Jamal, Amr; Temsah, Omar; Alzamil, Fahad; Somily, Ali; Al-Tawfiq, Jaffar A.
Afiliação
  • Barry M; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, King Saud University and King Saud University Medical City, Riyadh, Saudi Arabia. Electronic address: mbarry@ksu.edu.sa.
  • Temsah MH; Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Aljamaan F; College of Medicine, King Saud University, Riyadh, Saudi Arabia; Critical Care Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia.
  • Saddik B; Sharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates; Department of Family and Community Medicine, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
  • Al-Eyadhy A; Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alenezi S; Department of Psychiatry, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alamro N; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alhuzaimi AN; College of Medicine, King Saud University, Riyadh, Saudi Arabia; Division of Pediatric Cardiology, Department of Cardiac Sciences, King Saud University Medical City, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Heart Center, King Faisal Specialist Hospital & Research Center,
  • Alhaboob A; Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alhasan K; Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alsohime F; Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alaraj A; Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia; Department of Medicine, College of Medicine, Qassim University, Qassim, Saudi Arabia.
  • Halwani R; Sharjah Institute of Medical Research, University of Sharjah, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
  • Jamal A; College of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Family and Community Medicine, King Saud University Medical City, Riyadh, Saudi Arabia; Evidence-Based Health Care & Knowledge Translation Research Chair, King Saud University, Riyadh, Saudi Arabia.
  • Temsah O; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Alzamil F; Pediatric Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Somily A; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Al-Tawfiq JA; Specialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Infectious Disease Division, Department of Medicine, Johns Hopkins University
Vaccine ; 39(40): 5762-5768, 2021 09 24.
Article em En | MEDLINE | ID: mdl-34481700
ABSTRACT

BACKGROUND:

The Kingdom of Saudi Arabia (KSA) was the fourth country in the world to authorize the BNT162b2 coronavirus disease 2019 (COVID-19) vaccine, which it rolled out on December 17, 2020 and first targeted at healthcare workers (HCWs). This study assesses vaccine uptake among this group during the first month of its availability.

METHODS:

A national cross-sectional, pilot-validated, self-administered survey was conducted among HCWs in the KSA between December 27, 2020 and January 3, 2021. The survey included sociodemographic details, previous contact with COVID-19 patients, previous infection with COVID-19, receiving (or registering with the Ministry of Health website to receive) the COVID-19 vaccine, sources of HCWs' information on vaccines, awareness of emerging variants of concern, and anxiety level using the 7-item Generalized Anxiety Disorder assessment. A descriptive bivariate analysis and multivariate logistic binary regression analysis were performed. The primary evaluated outcome was vaccine uptake.

RESULTS:

Of the 1058 participants who completed the survey, 704 (66.5%) were female, and 626 (59.2%) were nurses. Of all the respondents, 352 (33.27%) were enrolled to receive or had already received the vaccine, while 706 (66.73%) had not enrolled. In a bivariate analysis, not enrolling for vaccination was more likely in females than males (78.5% vs. 21.5%, P < 0.001), HCWs between the ages of 20 and 40 years than those >40 years (70.4% vs. 29.6%, P = 0.005), Saudi HCWs than expatriates (78% vs 22%, P < 0.001), and among HCWs who used social media as a source of information than those who did not (69.8% vs. 38.6%, P < 0.001). In a multivariate analysis, independent factors associated with uptake were being a Saudi national (aOR = 1.918, 95 %CI = 1.363-2.698, P < 0.001), working in an intensive care unit (aOR = 1.495, 95 %CI = 1.083-2.063, P = 0.014), and working at a university hospital (aOR = 1.867, 95 %CI = 1.380-2.525, P < 0.001).

CONCLUSIONS:

A low level of vaccine uptake was observed especially in female HCWs, those younger than 40 years old, and those who used social media as their source of vaccine information. This survey provides important information for public health authorities in order to scale up vaccination campaigns targeting these HCWs to increase vaccine enrollment and uptake.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article